investor losses

Law firm sues Richtech Robotics for securities fraud over false Microsoft partnership claims made January 27-29, 2026. Investors can apply as lead plaintiffs by April 3.

Portnoy Law Firm files class action against $IT on behalf of investors, alleging false statements about contract value growth and consulting revenue amid massive stock declines.

Shareholder lawsuits against Nektar Therapeutics ($NKTR) and Eos Energy ($EOSE) allege clinical trial and production capacity disclosure failures, with lead plaintiff deadlines in April-May 2026.

Aldeyra Therapeutics ($ALDX) shares crashed 65% following FDA rejection of reproxalap for dry eye disease. Law firm Block & Leviton investigates potential securities fraud.

Shareholder lawsuits target $KD and $QURE over alleged disclosure violations, with lead plaintiff applications due April 13, 2026. Affected investors may pursue recovery.

Four companies face securities fraud lawsuits alleging false business disclosures. Investors have until April 2026 to file lead plaintiff motions.

Johnson Fistel investigates Aldeyra Therapeutics after FDA rejects lead drug reproxalap. Stock tumbles over 70% on March 17, 2026 announcement.

Green Dot shares fell 7% after delaying Q4/2025 earnings, triggering securities investigation by Johnson Fistel examining potential disclosure violations.

CRMT shares fell 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year, prompting securities investigation.

PennyMac Financial Services stock crashed 33% following Q4 2025 earnings miss, triggering securities investigation and class action lawsuit preparation by Rosen Law Firm.

Johnson Fistel investigates Lifecore Biomedical over 15-18% revenue miss and 18% stock decline, offering shareholder recovery options for alleged securities law violations.

Hub Group disclosed accounting errors requiring restatement of Q1-Q3 2025 financials, triggering 18.3% stock decline. Law firm investigates shareholder claims.

Apollo Global Management faces securities fraud class action after DOJ files reveal undisclosed business dealings with Jeffrey Epstein, contradicting prior denials. Stock fell 5%.

Soleno Therapeutics faces class action lawsuit for allegedly concealing drug safety risks including fluid retention and diabetes complications. Affected shareholders can claim losses through May 2026.

DNOW shares fell 19.1% after missing Q4 2025 earnings expectations. The Rosen Law Firm is investigating potential securities claims on behalf of affected investors.

Faruqi & Faruqi investigates Zynex securities fraud claims over alleged revenue inflation. Investor lawsuit deadline: April 21, 2026.

Law Offices of Howard G. Smith launches fraud lawsuits against $SDM, $BRBR, $METC, and $CLEUF, alleging market manipulation, misrepresentation, and pump-and-dump schemes.

Johnson Fistel investigates potential securities fraud at Horizon Technology Finance after stock plummeted 23% following disappointing Q4 2025 earnings guidance.

Lawsuit alleges Ostin Technology orchestrated fraud scheme causing $950M+ investor losses between May-June 2025. Lead plaintiff deadline set for April 17, 2026.

Inovio Pharmaceuticals faces class action securities fraud lawsuit alleging false statements about manufacturing capabilities and regulatory timelines. Investors have until April 7, 2026 to join.